GARDASIL 9 shows positive long-term results against HPV-related cancers
The effects of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in patients aged 9 to 15 years has indicated efficacy, according to a recent long-term follow-up study.
S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH
On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.
Ultrasonography models effective at determining lesion type
In a recent study, high sensitivity and specificity were found for differentiating between benign and malignant lesions when using the Assessment of Different Neoplasias in the Adnexa and Ovarian-Adnexal Reporting and Data System models.
The value of HPV self-sampling kits
Jeff Andrews, MD, FRCSC, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD, discusses the link between human papillomavirus (HPV) and cervical cancer, and how HPV self-sampling kits may increase rates of cervical cancer screening.
At-home HPV kits increase cervical cancer screenings
In a recent study, under-screened patients were more likely to receive cervical cancer screening after receiving at-home high-risk human papillomavirus sampling kits.
Efficacy of interventions for women-based cancer screenings
In a recent study, patients receiving interventions designed to increase adherence to screenings for breast, cervical, or colorectal cancers were more likely to be up to date on any or all screenings.
2 Clarke Drive Cranbury, NJ 08512